Patient (n = 14)	PVP+ (n = 8)	PVP‐ (n = 6)	p
Male Gender (n,%)	10 (71.4%)	7 (87.5%)	3 (50%)	0.25
Age (years)	56.64 ± 12.11	56.17 ± 13.21	57.0 ± 12.14	0.92
PAF (n,%)	9 (64.3%)	4 (50%)	5 (83.3%)	0.30
BMI (kg/m 2 )	23.77 ± 3.29	23.37 ± 4.16	24.07 ± 2.74	0.76
AF duration (months)	70.29 ± 47.90	48.0 ± 44.07	87.0 ± 46.1	0.06
Second ablation timing since de novo procedure (months)	14.79 ± 8.90	10.50 ± 3.93	20.50 ± 10.77	0.044
LVEDD (mm)	49.07 ± 5.01	49.0 ± 4.05	49.13 ± 5.91	0.88
LVEF (%)	59.50 ± 11.18	56.67 ± 13.20	61.63 ± 9.78	0.60
E/Em	8.48 ± 1.97	9.83 ± 1.86	7.52 ± 1.50	0.07
LA volume index (mL/m 2 )	41.54 ± 9.42	40.20 ± 10.45	42.54 ± 9.16	0.66
LA dimension (mm)	40.43 ± 6.02	40.83 ± 6.74	40.13 ± 5.90	0.84
Tricuspid regurgitation jet	2.13 ± 0.3	2.1 ± 0.3	2.2 ± 0.3	0.30
RVSP (mmHg)	24.4 ± 5.5	22.0 ± 5.2	26.8 ± 5.2	0.14
De novo procedure	PVs (n = 44)	PVP+(=13)	PVP‐(n = 31)	p
Time to isolation (s)	330.6 ± 128.9	378.1 ± 169.1	310.7 ± 104.9	0.28
Thawing time (s)	10.9 ± 6.3	10.0 ± 4.6	11.4 ± 6.9	0.8
Times (n)	2.1 ± 1.1	2.2 ± 1.2	2.0 ± 1.0	0.5
Nadir temperature (°C)	−50.1 ± 7.9	−48.8 ± 6.0	−50.7 ± 8.7	0.49
Single‐shot (n,%)	29 (65.9%)	9 (69.2%)	20 (64.5%)	0.98
Ostium long (mm)	19.6 ± 3.2	19.5 ± 2.4	19.7 ± 3.6	0.82
Ostium short (mm)	13.6 ± 3.4	13.4 ± 4.1	13.7 ± 3.2	0.44
Antrum long (mm)	21.2 ± 3.3	21.5 ± 2.7	21.1 ± 3.5	0.59
Antrum short (mm)	16.0 ± 4.5	16.2 ± 4.0	16.0 ± 4.8	0.94